Binding of Mucin by E. coli from Human Gut


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Cells of E. coli isolates from the gut of healthy volunteers (N=5) and patients with Crohn’s disease (N=5) and laboratory E. coli strain DH5α bound mucin in vitro in similar amounts ranging from 0.02 to 0.12 mg/mg of bacterial dry weight. Binding was evaluated by the decrease in optical absorption of mucin solution at 214 nm after incubation with bacteria. Detailed analysis of mucin binding by one of isolates showed that during incubation of 0.09 mg/ml bacteria in 0.15 M NaCl containing 0.1 mg/ml mucin at 25oC, maximum binding was reached in 30 min, while in the presence of 14 mM α-methyl mannoside, mucin binding decreased by 46% (p<0.05). Confocal microscopy revealed intensive binding of FITC-labeled mucin to the surface of a small number of bacterial cells. Mucin binding did not significantly affect zeta potential of bacteria and their energetic status assessed by ATP content; at the same time, ATP content in the extracellular environment slightly increased.

About the authors

T. V. Vakhrusheva

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

Yu. P. Baikova

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

N. G. Balabushevich

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

S. A. Gusev

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

G. Yu. Lomakina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Russian Federation, Moscow

E. A. Sholina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Russian Federation, Moscow

M. A. Moshkovskaya

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

P. L. Shcherbakov

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

O. V. Pobeguts

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Russian Federation, Moscow

E. V. Mikhal’chik

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Author for correspondence.
Email: lemik2007@yandex.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies